Detection of clinically insignificant ISUP grade group 1 prostate cancer decreases by 57% under a prostate cancer screening strategy of MRI-targeted biopsy only rather than systematic biopsy in men ...
During clinical trials, Bristol Myers Squibb's KarXT was said to offer better treatment with fewer side effects. Meanwhile, Pfizer's sickle cell disease treatment Oxbryta was withdrawn from all ...
Most prostate cancers are “indolent,” meaning they’ll never metastasize during a patient’s lifetime and treatment could do more harm than good. At the same time, they’re the second highest cause of ...
France brushed off allegations of match-fixing after their 4-1 defeat against Iran sent them into the softest part of the draw at the Futsal World Cup in Uzbekistan. Les Bleus and ...
A new study demonstrates that the combination of lenalidomide (Revlimid) and obinutuzumab (Gazyva) is effective and well-tolerated in treating relapsed indolent non-Hodgkin lymphoma (NHL).
Amylou C. Dueck, Ph.D., a biostatistician specializing in hematologic malignancies, located at Mayo Clinic in Arizona. She is an NIH-funded researcher within the Department of Quantitative Health ...